- Report
- November 2021
- 1032 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- February 2022
- 128 Pages
Global
From €4275EUR$4,500USD£3,666GBP
Imaging biomarkers are a type of biomarker used to measure and monitor biological processes in the body. They are used to detect and diagnose diseases, assess the effectiveness of treatments, and monitor the progression of diseases. Imaging biomarkers are typically used in conjunction with other biomarkers, such as genetic and molecular biomarkers, to provide a more comprehensive picture of a patient's health. Imaging biomarkers can be used to detect changes in the structure and function of organs, tissues, and cells. Examples of imaging biomarkers include MRI, CT, PET, and ultrasound.
Imaging biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and radiology. They are also used in clinical trials to assess the safety and efficacy of new treatments. Imaging biomarkers are becoming increasingly important in the diagnosis and treatment of diseases, as they provide a more detailed picture of a patient's health.
Companies in the imaging biomarker market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems. Show Less Read more